Boston University Chobanian & Avedisian School of Medicine

Event

17th Annual Inflammatory Bowel Disease: The Art and Science in the Diagnosis and Treatment 2024

presented by Boston University Chobanian & Avedisian School of Medicine

10 others would like to attend.

Register Now

Notification icon Friday, September 13, 2024 12 PM - Saturday, September 14, 2024 3:40 PM US/Eastern

Location Icon Hilton Boston Park Plaza Hotel 50 Park Plaza Boston, MA 02116 United States

Event info

Overview

Each year, the Boston IBD conference  brings top gastroenterology specialists from North America together with up-and-coming Boston area specialists for a 1.5 day CE program. This program is designed to stimulate conversations about how to initiate practice changes within the IBD healthcare team in the diagnosis and management of patients with Crohn's disease (CD) and ulcerative colitis (UC).  Through keynote talks and panel discussions, you will be challenged to develop innovative strategies to improve the quality of life for your patients while prolonging clinical remission. The city of Boston provides an excellent backdrop for this educational and networking experience – we hope you can join us in person this year.

What past attendees have said about the Boston IBD Meeting:

  • Absolutely wonderful! Can't wait for next year!
  • This conference is such a gem and important resource for GI docs. This is a world class conference!
  • Excellent program very thoughtfully constructed!
  • Wonderful and as always highly educational! Provides useful information we can apply to our practice daily

Learning Objectives

At the conclusion of the activity, participants will be able to:

  1. Discuss the role of artificial intelligence in diagnosing and monitoring IBD.
  2. Describe emerging agents for IBD in terms of therapeutic target, safety and efficacy data, and place in therapy.
  3. Delineate the utility of point of care intestinal ultrasound as a modality in monitoring IBD disease activity.
  4. Apply patient-specific needs in selecting a biologic for a patient with IBD (personalized medicine). 
  5. Review the evidence regarding the role of therapeutic drug monitoring and combination therapy in pediatric and adult IBD
  6. Describe the risk factors for the development or intestinal cancer in IBD, and the role of surveillance.
  7. Characterize the hepatic extraintestinal manifestations of IBD, including hepatitis and primary sclerosing cholangitis.
  8. Plan to implement current approaches for the management of postoperative recurrence in CD.
  9. Describe the medical and surgical approaches in patients with severe UC and pouchitis.
  10. Discuss how health disparities and racism impact outcomes in IBD patients.
  11. Engage members of the interprofessional team (e.g., gastroenterologists, pharmacists, behavioral health) to support successful transition of patients from pediatric to adult care.

Target Audience

This course is designed for the  entire IBD healthcare team including gastroenterologists, pediatric gastroenterologists, colorectal surgeons, NP/PAs, nurses. pharmacists and other health care professionals caring for patients with CD and UC.

Accreditation

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Contact Hours: 10.77 of which TBD are eligible for pharmacology credit.

This activity is approved for 10.5 CPE credit(s).

Other Learners:  All other learners may claim a certificate of participation.  Consult your professional licensing board regarding the applicability and acceptance of certificates of participation for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABP
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 10.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

ABS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the various boards. 

 

For more information please visit the official event page.

Faculty
  • Athos Bousvaros

    Course Co-Director

  • Sonia Friedman

    Course Co-Director

  • Sharmeel Wasan

    Course Co-Director

10 others would like to attend.

Register Now


0 Comments
Login to view comments. Click here to Login